Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hematopoietic Cells
100%
Joint Inflammation
100%
Zymosan
100%
CD45+
100%
Naringenin
100%
Nrf2 Expression
100%
Citrus Flavonoids
100%
MRNA Expression
50%
Analgesic
37%
Interleukin-1β
25%
Oxidative Stress
25%
Inflammasome
25%
Edema
25%
Leukocyte Recruitment
25%
Anti-inflammatory Effect
25%
Articular Pain
25%
Zymosan-induced Arthritis
25%
Inflammatory Cytokines
12%
Intra-articular Injection
12%
Molecular Mechanism
12%
Inflammation
12%
Interleukin-33 (IL-33)
12%
Cellular Mechanisms
12%
Therapeutic Agents
12%
Biologically Active
12%
Interleukin-10
12%
Gp91phox
12%
Flavonoids
12%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
12%
NOD-like Receptor Protein 3 (NLRP3)
12%
Mechanical Hyperalgesia
12%
Histopathological Changes
12%
Caspase-1
12%
Heme oxygenase-1 (HO-1)
12%
Anti-inflammatory Mediators
12%
Superoxide Anion Production
12%
Nrf2 Gene
12%
GSH Level
12%
Antioxidant Flavonoids
12%
Physiopathological Mechanisms
12%
Histopathology
12%
Dose-dependent
12%
Synovial Cavity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Arthritis
100%
Zymosan
100%
Transcription Factor Nrf2
100%
Naringenin
100%
Flavanone
100%
Citrus
100%
Messenger RNA
50%
Analgesic Agent
37%
Anti-Inflammatory Drug
37%
Interleukin 1
25%
Inflammasome
25%
Edema
25%
Antiinflammatory Activity
25%
Zymosan-Induced Arthritis
25%
Tumor Necrosis Factor
12%
Cytokine
12%
Clinical Study
12%
Inflammation
12%
Superoxide
12%
Interleukin 10
12%
Interleukin 1beta Converting Enzyme
12%
Mechanical Hyperalgesia
12%
Flavonoid
12%
Flavonoid Antioxidants
12%
Immunology and Microbiology
Hematopoietic Cell
100%
Arthritis
100%
Citrus
100%
Transcription Factor Nrf2
100%
Interleukin 1
50%
Oxidative Stress
50%
Leukocyte Recruitment
50%
Antiinflammatory Activity
50%
Inflammasome
50%
Tumor Necrosis Factor
25%
Mediator
25%
Interleukin-33
25%
Proinflammatory Cytokine
25%
Interleukin 10
25%
Superoxide
25%
Upregulation
25%
Caspase 1
25%
Mechanical Hyperalgesia
25%
Inflammation
25%